SureTrader Nadex Advertisement
Home > Boards > US Listed > Biotechs >

Cellectar Biosciences Inc. (CLRB)

CLRB RSS Feed
Add CLRB Price Alert      Hide Sticky   Hide Intro
Moderator: Rymankoly, Crusader, Sunofwolf
Search This Board: 
Last Post: 2/27/2017 9:01:32 PM - Followers: 123 - Board type: Free - Posts Today: 0

Cellectar BioSciences
We are a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer. Our lead drug candidates are based on a cancer-targeting technology whereby our compounds are selectively taken up and retained in cancer cells (including cancer stem cells) versus normal cells. Thus, our compounds directly kill cancer cells while minimizing harm to normal cells. This offers the potential for a paradigm shift in cancer therapy - efficacy versus all three major drivers of mortality in cancer: primary tumors, metastases and stem cell-based relapse. More specifically, our technology enables targeted delivery to cancer cells of apoptosis-inducing Akt inhibition or, when a radioactive molecule is attached, of radiation sufficient to kill cancer cells. Other labeled variations of our compounds provide imaging agents for an accurate diagnosis of cancer, including metastases, and can also objectively measure therapeutic success. Together, we believe this platform is capable of yielding multiple, distinct oncology product opportunities which will enable us to "find, treat and follow" cancer anywhere in the body in a novel, highly selective way. 
http://cellectarbiosciences.com/wp-content/uploads/2015/05/CLRB-Corporate-Presentation-7-11-16.pdf
Document   
 
http://cellectar.com/news-investors/
Share Statistics
Avg Vol (3 month)3: 1,918,910
Avg Vol (10 day)3: 144,943
Shares Outstanding5: 5.37M
Float: 3.00M
% Held by Insiders1: 32.56%
% Held by Institutions1: 45.30%
Shares Short (as of Jul 15, 2016)3: 360.60K
Short Ratio (as of Jul 15, 2016)3: 0.54
Short % of Float (as of Jul 15, 2016)3: 11.25%
Shares Short (prior month)3: 450.22K

Investor Relations 
 

 

Stock Quote
Click to view Novelos Therapeutics' stock information 

SEC Documentation

Click to view SEC Documentation 

Analyst Coverage
Rodman & Renshaw
Elemer Piros, Ph.D.
Tel. 212.430.1759 / epiros@rodm.com

Transfer Agent
American Stock Transfer & Trust Co
www.amstock.com
Shareholder services: 800-937-5449

Corporate Governance

Click to view Code of Ethics
Click to view Audit Committee Charter
Click to view Compensation Committee Charter
Click to view Nominating and Corporate Governance Committee Charter

Website:

http://www.novelos.com/

Recent News:

http://finance.yahoo.com/news/Novelos-Therapeutics-Enrolls-bw-230803295.html?x=0&.v=1

-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

 

 

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
CLRB
Current Price
Volume:
Bid Ask Day's Range
SureTrader
News News Alert: Current Report Filing (8-k) 02/27/2017 04:09:18 PM
PostSubject
#5726  Sticky Note Agree the Float is tiny Regis999 02/18/17 04:22:31 PM
#5658  Sticky Note Important new CLRB analytic report: Crusader 02/13/17 04:14:54 PM
#5803   that's what ihub has-maybe not updated. Sunofwolf 02/27/17 09:01:32 PM
#5802   Read again: Rymankoly 02/27/17 06:58:21 PM
#5801   Its 1,000,000 2/27,short interest is down not up! Sunofwolf 02/27/17 06:37:06 PM
#5800   Short interest 2/15/2017 1,265,882 Rymankoly 02/27/17 04:51:36 PM
#5799   CLRB was being taken down in last minute, Crusader 02/27/17 04:13:21 PM
#5798   No I don't believe that-it seems to go Sunofwolf 02/27/17 04:10:28 PM
#5797   Free market analysis: buy the close? Crusader 02/27/17 03:48:25 PM
#5796   The shorts are eventually going to get their Snakers 02/27/17 03:35:37 PM
#5795   adding a year or more to cancer person Sunofwolf 02/27/17 01:46:15 PM
#5794   Thanks for the early news post, AO! Crusader 02/27/17 01:25:58 PM
#5793   Might hit $3 today-there was a lot of Sunofwolf 02/27/17 09:27:52 AM
#5792   Maybe soon, still needs P2 to start (March?) Rymankoly 02/27/17 09:22:49 AM
#5791   hey it hit $2.82! Sunofwolf 02/27/17 09:22:43 AM
#5790   could we have that $3 day? Sunofwolf 02/27/17 09:21:36 AM
#5789   $2.7 pre-market, SOW wake up! Rymankoly 02/27/17 09:07:32 AM
#5788   CLRB Huge news!!!! http://ih.advfn.com/p.php?pid=nmona&article=73959819&symbol=C AOuvier 02/27/17 09:06:56 AM
#5787   Cancer is horrible brought on by bad food,drugs Sunofwolf 02/26/17 10:19:54 AM
#5786   Support Cancer research-buy some stock and make dough Sunofwolf 02/25/17 05:04:13 PM
#5785   Dreams of a $10 a share price- Sunofwolf 02/25/17 02:33:43 PM
#5784   You will see this company grow huge this year! Sunofwolf 02/24/17 08:56:08 PM
#5783   Skepticism is healthy. Idealism is driven by want Snakers 02/24/17 06:42:24 PM
#5782   "Very good about putting out accurate info" Cshom67 02/24/17 06:15:35 PM
#5781   Yes they have received that - http://investor.cellectar.com/releasedetail.cfm?re Cshom67 02/24/17 06:01:32 PM
#5780   rubbish,they are very good about putting out accurate info Sunofwolf 02/24/17 05:38:09 PM
#5779   Orphan designation for CLR-131? Snakers 02/24/17 05:11:22 PM
#5778   Usually, they cannot start the Phase 2 until Cshom67 02/24/17 04:46:20 PM
#5777   Still no word of the ORR, which will Cshom67 02/24/17 04:36:28 PM
#5776   I will sleep just fine this weekend. This Snakers 02/24/17 04:20:41 PM
#5775   The Cohort 4 is ahead of the company guidance. Rymankoly 02/24/17 12:46:57 PM
#5774   SOW & RYMAN: evidence CLRB ahead of schedule, Crusader 02/24/17 12:32:28 PM
#5773   Ryman: I think Phase 2 is running now, Crusader 02/24/17 12:15:06 PM
#5772   Ph 2 coming soon! Sunofwolf 02/24/17 11:57:44 AM
#5771   I think this will be the start of Rymankoly 02/24/17 11:30:57 AM
#5770   http://cellectar.com/pdc-pipeline/ Crusader 02/24/17 11:24:50 AM
#5769   July first is the earliest Phase 2 Update, Crusader 02/24/17 10:48:16 AM
#5768   read it on the news release somewhere-when you Sunofwolf 02/24/17 09:52:14 AM
#5767   Can you please point me to the source Rymankoly 02/24/17 09:24:35 AM
#5766   It's ahead of schedule! Sunofwolf 02/24/17 08:13:11 AM
#5765   Are we really going to get Phase II tjguy 02/24/17 03:57:40 AM
#5764   SOW. Wishing your cat all the best, hope he Rymankoly 02/23/17 11:14:25 PM
#5763   One thing this company is different is they Sunofwolf 02/23/17 11:03:38 PM
#5762   Ditto. Snakers 02/23/17 09:46:33 PM
#5761   This is getting to be a great board! Crusader 02/23/17 07:23:03 PM
#5760   Everybody was waiting on the cohort 3 results. Snakers 02/23/17 07:13:04 PM
#5759   Now you got it !!! Rymankoly 02/23/17 06:53:29 PM
#5758   Goes up and down Sunofwolf 02/23/17 06:39:43 PM
#5757   coming back with a strong close Sunofwolf 02/23/17 03:39:45 PM
#5756   $2.01 to $2.03, was a good place to Rymankoly 02/23/17 02:07:33 PM
#5755   Ryman, I agree with you on that, Crusader 02/23/17 12:10:52 PM
#5754   read the 8k-very good progress being made! No Sunofwolf 02/23/17 11:29:48 AM
PostSubject